2011年度 - 総説論文

* correspondence

Miyawaki A.
Proteins on the move: insights gained from fluorescent protein technologies.
Nat. Rev. Mol. Cell Biol. 12 (10): 656-668, 2011.

*Yamauchi J, Ubara Y, Ikeda K, Takaichi K: Retroperitoneal liposarcoma with lamellar bone inside.
Lancet. 377: 941, 2011

*Suda T, Takubo K, Semenza GL.
Metabolic regulation of hematopoietic stem cells in the hypoxic niche.
Cell Stem Cell. 9:298-310, 2011.

Sugiyama T and *Nagasawa T.
Emergency Evacuation! Hematopoietic Niches Induce Cell Exit in Infection.
Immunity. 34: 463-465, 2011

Miyawaki A.
Development of Probes for Cellular Functions Using Fluorescent Proteins and Fluorescence Resonance Energy Transfer.
Annu Rev Biochem. 80: 357-373, 2011.

*Tanaka M. and Miyajima A.
Identification and isolation of adult liver stem/progenitor cells.
Methods in Molecular Biology. (Ed. Ochiya T., Humana Press) 826: 25-32, 2012.

*Taniuchi I　and Ellmeier W. Transcriptional and Epigenetic Regulation of CD4/CD8 Lineage Choice.
Adv in Immunol. 110:71-110, 2011.

*Matsumoto M.
Contrasting models for the roles of Aire in the differentiation program of epithelial cells in the thymic medulla.
Eur J Immunol. 41: 12-17, 2011.

*Takihara Y. Role for Geminin in sustaining the activity of hematopoietic stem cells.
Cell Cycle. 　10: 561-562, 2011.

*Koyasu S, Moro K.
Type 2 innate immune responses and the natural helper cell.
Immunology. 132: 475-81, 2011

Fujita T, *Fujii H.
Direct identification of insulator components by insertional chromatin immunoprecipitation.
PLoS One. 6: e26109, 2011.

*Koyasu S, Moro K.
Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population.
Curr Opin Allergy Clin Immunol. 11: 109-14, 2011

Naito T, Tanaka H, Naoe Y and Taniuchi I.
Transcriptional control of T cell development.
Int. Immunol. 23:661-8, 2011.

Harada Y, and *Harada H.
Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
J Cell Biochem. 112: 425-432, 2011.

Suzuki M, Shimizu R, *Yamamoto M.
Transcriptional regulation by GATA1 and GATA2 during erythropoiesis.
Int J Hematol. 93: 150-155, 2011.

*Itoh T., Tanaka M., and Miyajima A.
Liver stem cells.
Regenerative Medicine from protocol to patient. (Springer 327 Ed. G. Steinhoff) p327-349. 2011.

Nakanishi M.
Cell cycle.
Rinsho Ketsueki. 52(10):1660-8, 2011.

*Watanabe K, Ikeda K: Osteocytes in normal physiology and osteoporosis.
Clinic Rev Bone Miner Metab. 8: 224-232, 2010

*Watanabe K, Ikeda K: Chapter 9. Osteocytes in Mechanosensing: insights from mouse models and human patients.
In: “Mechanosensing Biology. ” (ed. Masaki Noda), p127-139, Springer, 2011

*Tsuneto M, Yamane T, and Hayashi SI.
Methods for investigation of osteoclastogenesis using mouse embryonic stem cells.
Methods in Molecular Biology. 690: 239-253, 2011.

Yokoyama Y, Nishikii H, and *Chiba S.
Hematopoietic differentiation from embryonic stem cells.
Embryonic Stem Cells. (Craig Atwood, INTECH, Rijeka, Croatia). 2011-03

田岡謙一、大越　靖、*千葉　滋
高齢者の中枢神経原発悪性リンパ腫をどこまで治療するか
血液内科．62: 707-712, 2011.

栗田尚樹、*千葉　滋
白血球減少症
診断と治療．99: 1137-1142, 2011.

坂田−柳元麻実子、*千葉　滋
Notchシグナルを標的にした分子標的治療薬の開発
血液内科．66: 568-57424-431, 2011.

p>*千葉 滋
急性放射性症候群（Acute Radiation Syndrome: ARS）〜東海村JCO自己被ばくと造血幹細胞移植
血液フロンティア．21: 1741-1745, 2011.

*Yokoyama Y
Hematopoietic stem cells and mature blood cells from pluripotent stem cells.
Nihon Rinsho. 69: 2137-2141, 2011.

*横山泰久
鉄欠乏性貧血の治療ー内服困難例．治療の終了基準を含めてー
Medical Practice.28:2179-2183,2011.